Recombinant Human HLA-A*0201 HBs Ag complex Protein (C-10His)

Product Specifications

Background

Hepatitis B virus (HBV) infection leads to a wide spectrum of liver diseases ranging from acute to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) . The hallmark of chronic HBV infection is the presence of hepatitis B surface antigen (HBsAg) positivity for ≥6 months. Many studies in different clinical settings of HBV infection have suggested serum HBsAg quantitation as a surrogate marker of HBV DNA levels. Many studies in different clinical settings of HBV infection have suggested serum HBsAg quantitation as a surrogate marker of HBV DNA levels.

Product Name Alternative

HLA-A*0201 HBs Ag complex Protein

Accession Number

P61769&A0A140T913

Host

Human cells

Endotoxin

<1 EU/µg as determined by LAL test.

Purity

Greater than 95% as determined by reducing SDS-PAGE

Form

Liquid

Molecular Weight

49 kDa

Shipping Conditions

The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below.

Storage Conditions

Store at -70°C/-20°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Formulation

Supplied as a 0.2 μm filtered solution of 20mM PB, 500mM NaCl, 5% Trehalose, 50% Glycerol, 0.06% Tween80, pH7.4.

Construct

Recombinant Human HLA-A*0201 HBs Ag complex Protein is produced by our Mammalian expression system and the target gene encoding (ILSPFLPLL) &Ile21-Met119&Gly25-Ile308 (Ala269Val) is expressed with a 10His tag at the C-terminus.